<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31817487</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>The Impact of Kinases in Amyotrophic Lateral Sclerosis at the Neuromuscular Synapse: Insights into BDNF/TrkB and PKC Signaling.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1578</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells8121578</ELocationID><Abstract><AbstractText>Brain-derived neurotrophic factor (BDNF) promotes neuron survival in adulthood in the central nervous system. In the peripheral nervous system, BDNF is a contraction-inducible protein that, through its binding to tropomyosin-related kinase B receptor (TrkB), contributes to the retrograde neuroprotective control done by muscles, which is necessary for motor neuron function. BDNF/TrkB triggers downstream presynaptic pathways, involving protein kinase C, essential for synaptic function and maintenance. Undeniably, this reciprocally regulated system exemplifies the tight communication between nerve terminals and myocytes to promote synaptic function and reveals a new view about the complementary and essential role of pre and postsynaptic interplay in keeping the synapse healthy and strong. This signaling at the neuromuscular junction (NMJ) could establish new intervention targets across neuromuscular diseases characterized by deficits in presynaptic activity and muscle contractility and by the interruption of the connection between nervous and muscular tissues, such as amyotrophic lateral sclerosis (ALS). Indeed, exercise and other therapies that modulate kinases are effective at delaying ALS progression, preserving NMJs and maintaining motor function to increase the life quality of patients. Altogether, we review synaptic activity modulation of the BDNF/TrkB/PKC signaling to sustain NMJ function, its and other kinases' disturbances in ALS and physical and molecular mechanisms to delay disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanuza</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-4795-4103</Identifier><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Just-Borr&#xe0;s</LastName><ForeName>Laia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurtado</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cilleros-Ma&#xf1;&#xe9;</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tom&#xe0;s</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Neus</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3401-8335</Identifier><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tom&#xe0;s</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0406-0006</Identifier><AffiliationInfo><Affiliation>Unitat d'Histologia i Neurobiologia (UHNEUROB), Universitat Rovira i Virgili, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Sant Lloren&#xe7; 21, 43201 Reus, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>7171WSG8A2</RegistryNumber><NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D020813">Receptor, trkB</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C000591259">tropomyosin-related kinase-B, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020813" MajorTopicYN="N">Receptor, trkB</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">NMJ</Keyword><Keyword MajorTopicYN="N">PKC</Keyword><Keyword MajorTopicYN="N">TrkB</Keyword><Keyword MajorTopicYN="N">exercise</Keyword><Keyword MajorTopicYN="N">kinase</Keyword><Keyword MajorTopicYN="N">neuromuscular</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31817487</ArticleId><ArticleId IdType="pmc">PMC6953086</ArticleId><ArticleId IdType="doi">10.3390/cells8121578</ArticleId><ArticleId IdType="pii">cells8121578</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., de Winter F., Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:1&#x2013;18. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S., Santos A.F., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006;9:408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2005;490:209&#x2013;219. doi: 10.1002/cne.20620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20620</ArticleId><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Williamson T.L. Slowing of axonal transport is a very early event in the toxicity ofALS&#x2013;linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999;2:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K.M., Haddad F., Pandorf C.E., Roy R.R., Edgerton V.R. Alterations in muscle mass and contractile phenotype in response to unloading models: Role of transcriptional/pretranslational mechanisms. Front. Physiol. 2013;4:1&#x2013;13. doi: 10.3389/fphys.2013.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00284</ArticleId><ArticleId IdType="pmc">PMC3795307</ArticleId><ArticleId IdType="pubmed">24130531</ArticleId></ArticleIdList></Reference><Reference><Citation>Iizuka K., Machida T., Hirafuji M. Skeletal muscle is an endocrine organ. J. Pharm. Sci. 2014;125:125&#x2013;131. doi: 10.1254/jphs.14R02CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1254/jphs.14R02CP</ArticleId><ArticleId IdType="pubmed">24859778</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012;8:457&#x2013;465. doi: 10.1038/nrendo.2012.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.49</ArticleId><ArticleId IdType="pubmed">22473333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Xiong W.C., Mei L. To build a synapse: Signaling pathways in neuromuscular junction assembly. Development. 2010;137:1017&#x2013;1033. doi: 10.1242/dev.038711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.038711</ArticleId><ArticleId IdType="pmc">PMC2835321</ArticleId><ArticleId IdType="pubmed">20215342</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanelli J.T., Hoch W., Rupp F., Kreiner T., Scheller R.H. Agrin mediates cell contact-induced acetylcholine receptor clustering. Cell. 1991;67:909&#x2013;916. doi: 10.1016/0092-8674(91)90364-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90364-5</ArticleId><ArticleId IdType="pubmed">1659950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Noakes P.G., Moscoso L., Rupp F., Scheller R.H., Merlie J.P., Sanes J.R. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 1996;85:525&#x2013;535. doi: 10.1016/S0092-8674(00)81253-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81253-2</ArticleId><ArticleId IdType="pubmed">8653788</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox M.A., Sanes J.R., Borza D.-B., Eswarakumar V.P., F&#xe4;ssler R., Hudson B.G., John S.W.M., Ninomiya Y., Pedchenko V., Pfaff S.L., et al. Distinct Target-Derived Signals Organize Formation, Maturation, and Maintenance of Motor Nerve Terminals. Cell. 2007;129:179&#x2013;193. doi: 10.1016/j.cell.2007.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.035</ArticleId><ArticleId IdType="pubmed">17418794</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimune H., Valdez G., Jarad G., Moulson C.L., M&#xfc;ller U., Miner J.H., Sanes J.R. Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. J. Cell Biol. 2008;182:1201&#x2013;1215. doi: 10.1083/jcb.200805095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200805095</ArticleId><ArticleId IdType="pmc">PMC2542479</ArticleId><ArticleId IdType="pubmed">18794334</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimune H., Sanes J.R., Carlson S.S. A synaptic laminin&#x2013;calcium channel interaction organizes active zones in motor nerve terminals. Nature. 2004;432:580&#x2013;587. doi: 10.1038/nature03112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03112</ArticleId><ArticleId IdType="pubmed">15577901</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal N., Martin P.T. Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction. Dev. Neurobiol. 2011;71:982&#x2013;1005. doi: 10.1002/dneu.20953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20953</ArticleId><ArticleId IdType="pmc">PMC3472639</ArticleId><ArticleId IdType="pubmed">21766463</ArticleId></ArticleIdList></Reference><Reference><Citation>Polo-Parada L., Bose C.M., Landmesser L.T. Alterations in Transmission, Vesicle Dynamics, and Transmitter Release Machinery at NCAM-Deficient Neuromuscular Junctions. Neuron. 2001;32:815&#x2013;828. doi: 10.1016/S0896-6273(01)00521-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00521-9</ArticleId><ArticleId IdType="pubmed">11738028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Sanchez H.B., Deerinck T., Morris J.K., Ellisman M., Lee K.-F. Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc. Natl. Acad. Sci. USA. 2000;97:1299&#x2013;1304. doi: 10.1073/pnas.97.3.1299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.3.1299</ArticleId><ArticleId IdType="pmc">PMC15603</ArticleId><ArticleId IdType="pubmed">10655525</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonanno A., Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 2001;11:287&#x2013;296. doi: 10.1016/S0959-4388(00)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-4388(00)00210-5</ArticleId><ArticleId IdType="pubmed">11399426</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Xiong W.-C., Mei L. Neuromuscular Junction Formation, Aging, and Disorders. Annu. Rev. Physiol. 2018;80:159&#x2013;188. doi: 10.1146/annurev-physiol-022516-034255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034255</ArticleId><ArticleId IdType="pubmed">29195055</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Chakkalakal J.V. Current Topics in Developmental Biology. Academic Press; New York, NY, USA: 2018. The Composition, Development, and Regeneration of Neuromuscular Junctions; pp. 99&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">29305005</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudet C., Pozas E., Adameyko I., Andersson E., Ericson J., Ernfors P. Retrograde Signaling onto Ret during Motor Nerve Terminal Maturation. J. Neurosci. 2008;28:963&#x2013;975. doi: 10.1523/JNEUROSCI.4489-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4489-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671002</ArticleId><ArticleId IdType="pubmed">18216204</ArticleId></ArticleIdList></Reference><Reference><Citation>Je H.S., Yang F., Ji Y., Potluri S., Fu X.-Q., Luo Z.-G., Nagappan G., Chan J.P., Hempstead B., Son Y.-J., et al. ProBDNF and mature BDNF as punishment and reward signals for synapse elimination at mouse neuromuscular junctions. J. Neurosci. 2013;33:9957&#x2013;9962. doi: 10.1523/JNEUROSCI.0163-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0163-13.2013</ArticleId><ArticleId IdType="pmc">PMC3682390</ArticleId><ArticleId IdType="pubmed">23761891</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Q.T. Hyperinnervation of Neuromuscular Junctions Caused by GDNF Overexpression in Muscle. Science. 1998;279:1725&#x2013;1729. doi: 10.1126/science.279.5357.1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.279.5357.1725</ArticleId><ArticleId IdType="pubmed">9497292</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Ko C.-P. Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J. Neurosci. 2008;28:9599&#x2013;9609. doi: 10.1523/JNEUROSCI.2589-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2589-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844879</ArticleId><ArticleId IdType="pubmed">18815246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes-Medel Y., Ashley J., Barria R., Maloney R., Freeman M., Budnik V. Integration of a Retrograde Signal during Synapse Formation by Glia-Secreted TGF-&#x3b2; Ligand. Curr. Biol. 2012;22:1831&#x2013;1838. doi: 10.1016/j.cub.2012.07.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2012.07.063</ArticleId><ArticleId IdType="pmc">PMC3605899</ArticleId><ArticleId IdType="pubmed">22959350</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews V.B., &#xc5;str&#xf6;m M.-B., Chan M.H.S., Bruce C.R., Krabbe K.S., Prelovsek O., &#xc5;kerstr&#xf6;m T., Yfanti C., Broholm C., Mortensen O.H., et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009;52:1409&#x2013;1418. doi: 10.1007/s00125-009-1364-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1364-1</ArticleId><ArticleId IdType="pubmed">19387610</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitts E.V., Potluri S., Hess D.M., Balice-Gordon R.J. Neurotrophin and Trk-mediated signaling in the neuromuscular system. Int. Anesth. Clin. 2006;44:21&#x2013;76. doi: 10.1097/00004311-200604420-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004311-200604420-00004</ArticleId><ArticleId IdType="pubmed">16849956</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi H. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J. Cell Biol. 1993;123:455&#x2013;465. doi: 10.1083/jcb.123.2.455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.123.2.455</ArticleId><ArticleId IdType="pmc">PMC2119843</ArticleId><ArticleId IdType="pubmed">8408225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisterna B.A., Cardozo C., Saez J.C. Neuronal involvement in muscular atrophy. Front. Cell. Neurosci. 2014;8:1&#x2013;11. doi: 10.3389/fncel.2014.00405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00405</ArticleId><ArticleId IdType="pmc">PMC4261799</ArticleId><ArticleId IdType="pubmed">25540609</ArticleId></ArticleIdList></Reference><Reference><Citation>Minic J., Molg&#xf3; J., Karlsson E., Krejci E. Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur. J. Neurosci. 2002;15:439&#x2013;448. doi: 10.1046/j.0953-816x.2001.01875.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0953-816x.2001.01875.x</ArticleId><ArticleId IdType="pubmed">11876771</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; M.M., Salon I., Garcia N., Lanuza M.A., Uchitel O.D., Tom&#xe0;s J. Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat. Eur. J. Neurosci. 2003;17:119&#x2013;127. doi: 10.1046/j.1460-9568.2003.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.2003.02428.x</ArticleId><ArticleId IdType="pubmed">12534975</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; M.M., Salon I., Garcia N., Lanuza M.A., Uchitel O.D., Tom&#xe0;s J. Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions. Neuroscience. 2004;123:61&#x2013;73. doi: 10.1016/j.neuroscience.2003.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2003.09.012</ArticleId><ArticleId IdType="pubmed">14667442</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; M.M., Lanuza M.A., Garcia N., Tom&#xe0;s J. Calcium inflow-dependent protein kinase C activity is involved in the modulation of transmitter release in the neuromuscular junction of the adult rat. Synapse. 2005;57:76&#x2013;84. doi: 10.1002/syn.20159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20159</ArticleId><ArticleId IdType="pubmed">15906390</ArticleId></ArticleIdList></Reference><Reference><Citation>Slutsky I., Parnas H., Parnas I. Presynaptic effects of muscarine on ACh release at the frog neuromuscular junction. J. Physiol. 1999;514:769&#x2013;782. doi: 10.1111/j.1469-7793.1999.769ad.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1999.769ad.x</ArticleId><ArticleId IdType="pmc">PMC2269098</ArticleId><ArticleId IdType="pubmed">9882749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurtado E., Cilleros V., Nadal L., Sim&#xf3; A., Obis T., Garcia N., Santaf&#xe9; M.M., Tom&#xe0;s M., Halievski K., Jordan C.L., et al. Muscle Contraction Regulates BDNF/TrkB Signaling to Modulate Synaptic Function through Presynaptic cPKC&#x3b1; and cPKC&#x3b2;I. Front. Mol. Neurosci. 2017;10:1&#x2013;22. doi: 10.3389/fnmol.2017.00147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00147</ArticleId><ArticleId IdType="pmc">PMC5436293</ArticleId><ArticleId IdType="pubmed">28572757</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.-J., Tkatch T., Surmeier D.J. Adenosine Receptor Expression and Modulation of Ca2+ Channels in Rat Striatal Cholinergic Interneurons. J. Neurophysiol. 2000;83:322&#x2013;332. doi: 10.1152/jn.2000.83.1.322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2000.83.1.322</ArticleId><ArticleId IdType="pubmed">10634875</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom&#xe0;s J., Garcia N., Lanuza M.A., Santaf&#xe9; M.M., Tom&#xe0;s M., Nadal L., Hurtado E., Sim&#xf3;-Oll&#xe9; A., Cilleros-Ma&#xf1;&#xe9; V., Just-Borr&#xe0;s L. Adenosine Receptors in Developing and Adult Mouse Neuromuscular Junctions and Functional Links With Other Metabotropic Receptor Pathways. Front. Pharm. 2018;9:1&#x2013;10. doi: 10.3389/fphar.2018.00397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00397</ArticleId><ArticleId IdType="pmc">PMC5928480</ArticleId><ArticleId IdType="pubmed">29740322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3; A., Just-Borr&#xe0;s L., Cilleros-Ma&#xf1;&#xe9; V., Hurtado E., Nadal L., Tom&#xe0;s M., Garcia N., Lanuza M.A., Tom&#xe0;s J. BDNF-TrkB Signaling Coupled to nPKC&#x3b5; and cPKC&#x3b2;I Modulate the Phosphorylation of the Exocytotic Protein Munc18-1 During Synaptic Activity at the Neuromuscular Junction. Front. Mol. Neurosci. 2018;11:207&#x2013;227. doi: 10.3389/fnmol.2018.00207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00207</ArticleId><ArticleId IdType="pmc">PMC6007318</ArticleId><ArticleId IdType="pubmed">29946239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3; A., Cilleros-Ma&#xf1;&#xe9; V., Just-Borr&#xe0;s L., Hurtado E., Nadal L., Tom&#xe0;s M., Garcia N., Lanuza M.A., Tom&#xe0;s J. nPKC&#x3b5; Mediates SNAP-25 Phosphorylation of Ser-187 in Basal Conditions and After Synaptic Activity at the Neuromuscular Junction. Mol. Neurobiol. 2019;56:5346&#x2013;5364. doi: 10.1007/s12035-018-1462-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1462-5</ArticleId><ArticleId IdType="pubmed">30607888</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider W.D. How do you feel? Neurotrophins and mechanotransduction. Nat. Neurosci. 1998;1:5&#x2013;6. doi: 10.1038/199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/199</ArticleId><ArticleId IdType="pubmed">10195097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantilla C.B., Stowe J.M., Sieck D.C., Ermilov L.G., Greising S.M., Zhang C., Shokat K.M., Sieck G.C. TrkB kinase activity maintains synaptic function and structural integrity at adult neuromuscular junctions. J. Appl. Physiol. 2014;117:910&#x2013;920. doi: 10.1152/japplphysiol.01386.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.01386.2013</ArticleId><ArticleId IdType="pmc">PMC4199990</ArticleId><ArticleId IdType="pubmed">25170066</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang E.J., Reichardt L.F. Trk Receptors: Roles in Neuronal Signal Transduction. Annu. Rev. Biochem. 2003;72:609&#x2013;642. doi: 10.1146/annurev.biochem.72.121801.161629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161629</ArticleId><ArticleId IdType="pubmed">12676795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B. BDNF and Activity-Dependent Synaptic Modulation. Learn. Mem. 2003;10:86&#x2013;98. doi: 10.1101/lm.54603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/lm.54603</ArticleId><ArticleId IdType="pmc">PMC5479144</ArticleId><ArticleId IdType="pubmed">12663747</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Je H.-S., Ji Y., Nagappan G., Hempstead B., Lu B. Pro-BDNF-induced synaptic depression and retraction at developing neuromuscular synapses. J. Cell Biol. 2009;185:727&#x2013;741. doi: 10.1083/jcb.200811147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200811147</ArticleId><ArticleId IdType="pmc">PMC2711569</ArticleId><ArticleId IdType="pubmed">19451278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hempstead B.L. Dissecting the diverse actions of pro- and mature neurotrophins. Curr. Alzheimer Res. 2006;3:19&#x2013;24. doi: 10.2174/156720506775697061.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720506775697061</ArticleId><ArticleId IdType="pubmed">16472198</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichardt L.F. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. B. 2006;361:1545&#x2013;1564. doi: 10.1098/rstb.2006.1894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2006.1894</ArticleId><ArticleId IdType="pmc">PMC1664664</ArticleId><ArticleId IdType="pubmed">16939974</ArticleId></ArticleIdList></Reference><Reference><Citation>Middlemas D.S., Lindberg R.A., Hunter T. trkB, a neural receptor protein-tyrosine kinase: Evidence for a full-length and two truncated receptors. Mol. Cell. Biol. 1991;11:143&#x2013;153. doi: 10.1128/MCB.11.1.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.11.1.143</ArticleId><ArticleId IdType="pmc">PMC359604</ArticleId><ArticleId IdType="pubmed">1846020</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter G.T., Radeke M.J., Kuo R.C., Makrides V., Hinkle B., Hoang R., Medina-Selby A., Coit D., Valenzuela P., Feinstein S.C. Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2. J. Neurosci. 1997;17:2683&#x2013;2690. doi: 10.1523/JNEUROSCI.17-08-02683.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.17-08-02683.1997</ArticleId><ArticleId IdType="pmc">PMC6573096</ArticleId><ArticleId IdType="pubmed">9092589</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey S.G., Lovering R.M., Renn C.L., Leitch C.C., Liu X., Tallon L.J., Sadzewicz L.D., Pratap A., Ott S., Sengamalay N., et al. Genetic deletion of trkB.T1 increases neuromuscular function. Am. J. Physiol. 2012;302:141&#x2013;153. doi: 10.1152/ajpcell.00469.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00469.2010</ArticleId><ArticleId IdType="pmc">PMC3328911</ArticleId><ArticleId IdType="pubmed">21865582</ArticleId></ArticleIdList></Reference><Reference><Citation>Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.Y., Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 1996;16:3123&#x2013;3129. doi: 10.1523/JNEUROSCI.16-10-03123.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-10-03123.1996</ArticleId><ArticleId IdType="pmc">PMC2710135</ArticleId><ArticleId IdType="pubmed">8627351</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose C.R., Blum R., Pichler B., Lepier A., Kafitz K.W., Konnerth A. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature. 2003;426:74&#x2013;78. doi: 10.1038/nature01983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01983</ArticleId><ArticleId IdType="pubmed">14603320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J., Garner B. Evidence that truncated TrkB isoform, TrkB-Shc can regulate phosphorylated TrkB protein levels. Biochem. Biophys. Res. Commun. 2012;420:331&#x2013;335. doi: 10.1016/j.bbrc.2012.02.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.02.159</ArticleId><ArticleId IdType="pubmed">22425982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M., Ruggiero F.P., Chang Q., Shi Y.J., Rich M.M., Kraner S., Balice-Gordon R.J. Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron. 1999;24:567&#x2013;583. doi: 10.1016/S0896-6273(00)81113-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)81113-7</ArticleId><ArticleId IdType="pubmed">10595510</ArticleId></ArticleIdList></Reference><Reference><Citation>Haapasalo A., Koponen E., Hoppe E., Wong G., Castr&#xe9;n E. Truncated trkB.T1 Is Dominant Negative Inhibitor of trkB.TK+-Mediated Cell Survival. Biochem. Biophys. Res. Commun. 2001;280:1352&#x2013;1358. doi: 10.1006/bbrc.2001.4296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2001.4296</ArticleId><ArticleId IdType="pubmed">11162678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuppini R., Sartini S., Agostini D., Guescini M., Ambrogini P., Betti M., Bertini L., Vallasciani M., Stocchi V. Bdnf expression in rat skeletal muscle after acute or repeated exercise. Arch. Ital. Biol. 2007;145:99&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">17639782</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Pinilla F., Ying Z., Opazo P., Roy R.R., Edgerton V.R. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur. J. Neurosci. 2001;13:1078&#x2013;1084. doi: 10.1046/j.0953-816x.2001.01484.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0953-816x.2001.01484.x</ArticleId><ArticleId IdType="pubmed">11285004</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Pinilla F., Ying Z., Roy R.R., Molteni R., Edgerton V.R. Voluntary Exercise Induces a BDNF-Mediated Mechanism That Promotes Neuroplasticity. J. Neurophysiol. 2002;88:2187&#x2013;2195. doi: 10.1152/jn.00152.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00152.2002</ArticleId><ArticleId IdType="pubmed">12424260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Pinilla F., Ying Z., Zhuang Y. Brain and Spinal Cord Interaction: Protective Effects of Exercise Prior to Spinal Cord Injury. PLoS ONE. 2012;7:32298. doi: 10.1371/journal.pone.0032298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032298</ArticleId><ArticleId IdType="pmc">PMC3284558</ArticleId><ArticleId IdType="pubmed">22384207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoladz J.A., Pilc A. The effect of physical activity on the brain derived neurotrophic factor: From animal to human studies. J. Physiol. Pharm. 2010;61:533&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">21081796</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlard P.A., Perreau V.M., Engesser-Cesar C., Cotman C.W. The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise. Neurosci. Lett. 2004;363:43&#x2013;48. doi: 10.1016/j.neulet.2004.03.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2004.03.058</ArticleId><ArticleId IdType="pubmed">15157993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liem R., Brouwer N., Copray J. Ultrastructural localisation of intramuscular expression of BDNF mRNA by silver-gold intensified non-radioactive in situ hybridisation. Histochem. Cell Biol. 2001;116:545&#x2013;551. doi: 10.1007/s00418-001-0349-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-001-0349-z</ArticleId><ArticleId IdType="pubmed">11810196</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen B.K. Physical activity and muscle&#x2013;brain crosstalk. Nat. Rev. Endocrinol. 2019;15:383&#x2013;392. doi: 10.1038/s41574-019-0174-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0174-x</ArticleId><ArticleId IdType="pubmed">30837717</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Franke A., Wilkinson G.A., Kruttgen A., Hu M., Munro E., Hanson M.G., Reichardt L.F., Barres B.A. Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron. 1998;21:681&#x2013;693. doi: 10.1016/S0896-6273(00)80586-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80586-3</ArticleId><ArticleId IdType="pmc">PMC2693071</ArticleId><ArticleId IdType="pubmed">9808456</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloyz R., Fawcett J.P., Kaplan D.R., Murphy R.A., Miller F.D. Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. Learn. Mem. 1999;6:216&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC311290</ArticleId><ArticleId IdType="pubmed">10492004</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson S.L., Pittenger C., Morozov A., Martin K.C., Scanlin H., Drake C., Kandel E.R. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron. 2001;32:123&#x2013;140. doi: 10.1016/S0896-6273(01)00443-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00443-3</ArticleId><ArticleId IdType="pubmed">11604144</ArticleId></ArticleIdList></Reference><Reference><Citation>Skup M., Dwornik A., Macias M., Sulejczak D., Wiater M., Czarkowska-Bauch J. Long-term locomotor training up-regulates TrkB(FL) receptor-like proteins, brain-derived neurotrophic factor, and neurotrophin 4 with different topographies of expression in oligodendroglia and neurons in the spinal cord. Exp. Neurol. 2002;176:289&#x2013;307. doi: 10.1006/exnr.2002.7943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2002.7943</ArticleId><ArticleId IdType="pubmed">12359171</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiton M., Gunn-Moore F.J., Stitt T.N., Yancopoulos G.D., Tavar&#xe9; J.M. Identification of in vivo brain-derived neurotrophic factor-stimulated autophosphorylation sites on the TrkB receptor tyrosine kinase by site-directed mutagenesis. J. Biol. Chem. 1994;269:30370&#x2013;30377.</Citation><ArticleIdList><ArticleId IdType="pubmed">7982951</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.E., Stephens R.M., Kaplan D.R., Greene L.A. Autophosphorylation of activation loop tyrosines regulates signaling by the TRK nerve growth factor receptor. J. Biol. Chem. 1997;272:10957&#x2013;10967. doi: 10.1074/jbc.272.16.10957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.16.10957</ArticleId><ArticleId IdType="pubmed">9099755</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman W.J., Greene L.A. Neurotrophin Signaling via Trks and p75. Exp. Cell Res. 1999;253:131&#x2013;142. doi: 10.1006/excr.1999.4705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1999.4705</ArticleId><ArticleId IdType="pubmed">10579918</ArticleId></ArticleIdList></Reference><Reference><Citation>Middlemas D.S., Meisenhelder J., Hunter T. Identification of TrkB autophosphorylation sites and evidence that phospholipase C-gamma1 is a substrate of the TrkB receptor. J. Biol. Chem. 1994;269:5458&#x2013;5466.</Citation><ArticleIdList><ArticleId IdType="pubmed">8106527</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal R.A., Bhattacharyya A., Rua L.A., Alberta J.A., Stephens R.M., Kaplan D.R., Stiles C.D. Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 1996;271:20175&#x2013;20181. doi: 10.1074/jbc.271.33.20175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.33.20175</ArticleId><ArticleId IdType="pubmed">8702742</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter G., Ji Q. Phospholipase C-&#x3b3; as a Signal-Transducing Element. Exp. Cell Res. 1999;253:15&#x2013;24. doi: 10.1006/excr.1999.4671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1999.4671</ArticleId><ArticleId IdType="pubmed">10579907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleiman R.J., Tian N., Krizaj D., Hwang T.N., Copenhagen D.R., Reichardt L.F. BDNF-Induced potentiation of spontaneous twitching in innervated myocytes requires calcium release from intracellular stores. J. Neurophysiol. 2000;84:472&#x2013;483. doi: 10.1152/jn.2000.84.1.472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2000.84.1.472</ArticleId><ArticleId IdType="pmc">PMC2710114</ArticleId><ArticleId IdType="pubmed">10899220</ArticleId></ArticleIdList></Reference><Reference><Citation>Col&#xf3;n-Gonz&#xe1;lez F., Kazanietz M.G. C1 domains exposed: From diacylglycerol binding to protein-protein interactions. Biochim. Biophys. Acta. 2006;1761:827&#x2013;837. doi: 10.1016/j.bbalip.2006.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2006.05.001</ArticleId><ArticleId IdType="pubmed">16861033</ArticleId></ArticleIdList></Reference><Reference><Citation>Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer. 2007;7:281&#x2013;294. doi: 10.1038/nrc2110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2110</ArticleId><ArticleId IdType="pubmed">17384583</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendran A., Hare G.R., Kieloch A., Williams M.R., Alessi D.R. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett. 2000;484:217&#x2013;223. doi: 10.1016/S0014-5793(00)02162-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)02162-1</ArticleId><ArticleId IdType="pubmed">11078882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou M.M., Hou W., Johnson J., Graham L.K., Lee M.H., Chen C.-S., Newton A.C., Schaffhausen B.S., Toker A. Regulation of protein kinase C &#x3b6; by PI 3-kinase and PDK-1. Curr. Biol. 1998;8:1069&#x2013;1078. doi: 10.1016/S0960-9822(98)70444-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(98)70444-0</ArticleId><ArticleId IdType="pubmed">9768361</ArticleId></ArticleIdList></Reference><Reference><Citation>Keranen L.M., Dutil E.M., Newton A.C. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr. Biol. 1995;5:1394&#x2013;1403. doi: 10.1016/S0960-9822(95)00277-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(95)00277-6</ArticleId><ArticleId IdType="pubmed">8749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science. 1998;281:2042&#x2013;2045. doi: 10.1126/science.281.5385.2042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5385.2042</ArticleId><ArticleId IdType="pubmed">9748166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenburg E.D., Gao T., Newton A.C. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J. Biol. Chem. 2001;276:45289&#x2013;45297. doi: 10.1074/jbc.M107416200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M107416200</ArticleId><ArticleId IdType="pubmed">11579098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurtado E., Cilleros V., Just L., Sim&#xf3; A., Nadal L., Tom&#xe0;s M., Garcia N., Lanuza M.A., Tom&#xe0;s J. Synaptic Activity and Muscle Contraction Increases PDK1 and PKC&#x3b2;I Phosphorylation in the Presynaptic Membrane of the Neuromuscular Junction. Front. Mol. Neurosci. 2017;10:1&#x2013;13. doi: 10.3389/fnmol.2017.00270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00270</ArticleId><ArticleId IdType="pmc">PMC5574929</ArticleId><ArticleId IdType="pubmed">28890686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanuza M.A., Santafe M.M., Garcia N., Besalduch N., Tom&#xe0;s M., Obis T., Priego M., Nelson P.G., Tom&#xe0;s J. Protein kinase C isoforms at the neuromuscular junction: Localization and specific roles in neurotransmission and development. J. Anat. 2014;224:61&#x2013;73. doi: 10.1111/joa.12106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12106</ArticleId><ArticleId IdType="pmc">PMC3867888</ArticleId><ArticleId IdType="pubmed">24102585</ArticleId></ArticleIdList></Reference><Reference><Citation>Besalduch N., Tom&#xe0;s M., Santaf&#xe9; M.M., Garcia N., Tom&#xe0;s J., Lanuza M.A. Synaptic activity-related classical protein kinase C isoform localization in the adult rat neuromuscular synapse. J. Comp. Neurol. 2010;518:211&#x2013;228. doi: 10.1002/cne.22220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.22220</ArticleId><ArticleId IdType="pubmed">19937712</ArticleId></ArticleIdList></Reference><Reference><Citation>Obis T., Besalduch N., Hurtado E., Nadal L., Santafe M.M., Garcia N., Tom&#xe0;s M., Priego M., Lanuza M.A., Tom&#xe0;s J. The novel protein kinase C epsilon isoform at the adult neuromuscular synapse: Location, regulation by synaptic activity-dependent muscle contraction through TrkB signaling and coupling to ACh release. Mol. Brain. 2015;8:8. doi: 10.1186/s13041-015-0098-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0098-x</ArticleId><ArticleId IdType="pmc">PMC4348107</ArticleId><ArticleId IdType="pubmed">25761522</ArticleId></ArticleIdList></Reference><Reference><Citation>Obis T., Hurtado E., Nadal L., Tom&#xe0;s M., Priego M., Simon A., Garcia N., Santafe M.M., Lanuza M.A., Tom&#xe0;s J. The novel protein kinase C epsilon isoform modulates acetylcholine release in the rat neuromuscular junction. Mol. Brain. 2015;8:80. doi: 10.1186/s13041-015-0171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0171-5</ArticleId><ArticleId IdType="pmc">PMC4665914</ArticleId><ArticleId IdType="pubmed">26625935</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; M.M., Lanuza M.A., Garcia N., Tom&#xe0;s J. Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal. Eur. J. Neurosci. 2006;23:2048&#x2013;2056. doi: 10.1111/j.1460-9568.2006.04753.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2006.04753.x</ArticleId><ArticleId IdType="pubmed">16630052</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; M.M., Lanuza M.A., Garcia N., Tom&#xe0;s M., Tom&#xe0;s J.M. Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal. Neuroscience. 2007;148:432&#x2013;440. doi: 10.1016/j.neuroscience.2007.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2007.06.017</ArticleId><ArticleId IdType="pubmed">17681697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantilla C.B., Zhan W.-Z., Sieck G.C. Neurotrophins improve neuromuscular transmission in the adult rat diaphragm. Muscle Nerve. 2004;29:381&#x2013;386. doi: 10.1002/mus.10558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10558</ArticleId><ArticleId IdType="pubmed">14981737</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia N., Tom&#xe0;s M., Santaf&#xe9; M.M., Besalduch N., Lanuza M.A., Tom&#xe0;s J. The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals. J. Neurosci. 2010;30:16514&#x2013;16522. doi: 10.1523/JNEUROSCI.2676-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2676-10.2010</ArticleId><ArticleId IdType="pmc">PMC6634863</ArticleId><ArticleId IdType="pubmed">21147991</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; M.M., Garcia N., Tom&#xe0;s M., Obis T., Lanuza M.A., Besalduch N., Tom&#xe0;s J. The interaction between tropomyosin-related kinase B receptors and serine kinases modulates acetylcholine release in adult neuromuscular junctions. Neurosci. Lett. 2014;561:171&#x2013;175. doi: 10.1016/j.neulet.2013.12.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.12.073</ArticleId><ArticleId IdType="pubmed">24406154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pousinha P.A., Diogenes M.J., Ribeiro J.A., Sebasti&#xe3;o A.M. Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors. Neurosci. Lett. 2006;404:143&#x2013;147. doi: 10.1016/j.neulet.2006.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.05.036</ArticleId><ArticleId IdType="pubmed">16790314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom&#xe0;s J., Santaf&#xe9; M.M., Garcia N., Lanuza M.A., Tom&#xe0;s M., Besalduch N., Obis T., Priego M., Hurtado E. Presynaptic membrane receptors in acetylcholine release modulation in the neuromuscular synapse. J. Neurosci. Res. 2014;92:543&#x2013;554. doi: 10.1002/jnr.23346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23346</ArticleId><ArticleId IdType="pubmed">24464361</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan J., Noakes P.G., Bellingham M.C. The Role of Altered BDNF/TrkB Signaling in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2019;13:1&#x2013;16. doi: 10.3389/fncel.2019.00368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00368</ArticleId><ArticleId IdType="pmc">PMC6700252</ArticleId><ArticleId IdType="pubmed">31456666</ArticleId></ArticleIdList></Reference><Reference><Citation>Just-Borr&#xe0;s L., Hurtado E., Cilleros-Ma&#xf1;&#xe9; V., Biondi O., Charbonnier F., Tom&#xe0;s M., Garcia N., Lanuza M.A., Tom&#xe0;s J. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice. Mol. Neurobiol. 2019;56:6856&#x2013;6872. doi: 10.1007/s12035-019-1550-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1550-1</ArticleId><ArticleId IdType="pubmed">30929165</ArticleId></ArticleIdList></Reference><Reference><Citation>Harandi V.M., Gaied A.R.N., Br&#xe4;nnstr&#xf6;m T., Pedrosa Domell&#xf6;f F., Liu J.-X. Unchanged Neurotrophic Factors and Their Receptors Correlate With Sparing in Extraocular Muscles in Amyotrophic Lateral Sclerosis. Investig. Opthalmology Vis. Sci. 2016;57:6831&#x2013;6842. doi: 10.1167/iovs.16-20074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.16-20074</ArticleId><ArticleId IdType="pubmed">28002846</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Aguila J., Hoogstraaten R., Kee N., Hedlund E. Axon-Seq Decodes the Motor Axon Transcriptome and Its Modulation in Response to ALS. Stem Cell Rep. 2018;11:1565&#x2013;1578. doi: 10.1016/j.stemcr.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6294264</ArticleId><ArticleId IdType="pubmed">30540963</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforges S., Branchu J., Biondi O., Grondard C., Pariset C., L&#xe9;colle S., Lopes P., Vidal P.-P., Chanoine C., Charbonnier F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 2009;587:3561&#x2013;3571. doi: 10.1113/jphysiol.2009.169748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.169748</ArticleId><ArticleId IdType="pmc">PMC2742281</ArticleId><ArticleId IdType="pubmed">19491245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 2008;586:3337&#x2013;3351. doi: 10.1113/jphysiol.2007.149286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;st B.M., Copray J.C.V.M., Brouwer N., Troost D., Boddeke H.W.G.M. Elevated Levels of Neurotrophins in Human Biceps Brachii Tissue of Amyotrophic Lateral Sclerosis. Exp. Neurol. 2002;177:419&#x2013;427. doi: 10.1006/exnr.2002.8011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2002.8011</ArticleId><ArticleId IdType="pubmed">12429188</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T., Sobue G., Hamano T., Kuriyama M., Hirayama M., Yamamoto M., Mitsuma T. Decreased Phosphorylation Levels of TrkB Neurotrophin Receptor in the Spinal Cords from Patients with Amyotrophic Lateral Sclerosis. Neurochem. Res. 2000;25:239&#x2013;245. doi: 10.1023/A:1007575504321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1007575504321</ArticleId><ArticleId IdType="pubmed">10786708</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi H., Belluardo N., Arenas E., Yamamoto Y., Casabona A., Persson H., Ibanez C. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science. 1995;268:1495&#x2013;1499. doi: 10.1126/science.7770776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7770776</ArticleId><ArticleId IdType="pubmed">7770776</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.-L., Garc&#xed;a-Ayll&#xf3;n M.-S., Ciura S., S&#xe1;ez-Valero J., Kabashi E. Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front. Mol. Neurosci. 2016;9:160. doi: 10.3389/fnmol.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00160</ArticleId><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanpallewar S.U., Barrick C.A., Buckley H., Becker J., Tessarollo L. Deletion of the BDNF Truncated Receptor TrkB.T1 Delays Disease Onset in a Mouse Model of Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:1&#x2013;7. doi: 10.1371/journal.pone.0039946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039946</ArticleId><ArticleId IdType="pmc">PMC3384607</ArticleId><ArticleId IdType="pubmed">22761934</ArticleId></ArticleIdList></Reference><Reference><Citation>Delezie J., Weihrauch M., Maier G., Tejero R., Ham D.J., Gill J.F., Karrer-Cardel B., R&#xfc;egg M.A., Tabares L., Handschin C. BDNF is a mediator of glycolytic fiber-type specification in mouse skeletal muscle. Proc. Natl. Acad. Sci. USA. 2019;116:16111&#x2013;16120. doi: 10.1073/pnas.1900544116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1900544116</ArticleId><ArticleId IdType="pmc">PMC6690026</ArticleId><ArticleId IdType="pubmed">31320589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevrel G., Hohlfeld R., Sendtner M. The role of neurotrophins in muscle under physiological and pathological conditions. Muscle Nerve. 2006;33:462&#x2013;476. doi: 10.1002/mus.20444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20444</ArticleId><ArticleId IdType="pubmed">16228973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulakowski S.A., Parker S.D., Personius K.E. Reduced TrkB expression results in precocious age-like changes in neuromuscular structure, neurotransmission, and muscle function. J. Appl. Physiol. 2011;111:844&#x2013;852. doi: 10.1152/japplphysiol.00070.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00070.2011</ArticleId><ArticleId IdType="pubmed">21737823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs G., Penn R.D., York M., Giess R., Beck M., Tonn J., Haigh J., Malta E., Traub M., Sendtner M., et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:201&#x2013;206. doi: 10.1080/14660820050515197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515197</ArticleId><ArticleId IdType="pubmed">11464953</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M., Flachenecker P., Magnus T., Giess R., Reiners K., Toyka K.V., Naumann M. Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2005;6:100&#x2013;103. doi: 10.1080/14660820510028412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510028412</ArticleId><ArticleId IdType="pubmed">16036433</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee F.S., Chao M. V Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. USA. 2001;98:3555&#x2013;3560. doi: 10.1073/pnas.061020198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.061020198</ArticleId><ArticleId IdType="pmc">PMC30691</ArticleId><ArticleId IdType="pubmed">11248116</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R., Nanduri V., Jing S., Lamballe F., Tapley P., Bryant S., Cordon-Cardo C., Jones K.R., Reichardt L.F., Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 1991;66:395&#x2013;403. doi: 10.1016/0092-8674(91)90628-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90628-C</ArticleId><ArticleId IdType="pmc">PMC2710095</ArticleId><ArticleId IdType="pubmed">1649702</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker P.A. p75NTR is positively promiscuous: Novel partners and new insights. Neuron. 2004;42:529&#x2013;533. doi: 10.1016/j.neuron.2004.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.04.001</ArticleId><ArticleId IdType="pubmed">15157416</ArticleId></ArticleIdList></Reference><Reference><Citation>Bibel M., Hoppe E., Barde Y.A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. Embo. J. 1999;18:616&#x2013;622. doi: 10.1093/emboj/18.3.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.3.616</ArticleId><ArticleId IdType="pmc">PMC1171154</ArticleId><ArticleId IdType="pubmed">9927421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nykjaer A., Willnow T.E., Petersen C.M. p75NTR&#x2014;live or let die. Curr. Opin. Neurobiol. 2005;15:49&#x2013;57. doi: 10.1016/j.conb.2005.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2005.01.004</ArticleId><ArticleId IdType="pubmed">15721744</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Lee X., Shao Z., Apicco D., Huang G., Gong B.J., Pepinsky R.B., Mi S. A DR6/p75(NTR) complex is responsible for &#x3b2;-amyloid-induced cortical neuron death. Cell Death Dis. 2013;4:e579. doi: 10.1038/cddis.2013.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.110</ArticleId><ArticleId IdType="pmc">PMC3641333</ArticleId><ArticleId IdType="pubmed">23559013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry K.S., Murray S.S., McLean C.A., Talman P., Mathers S., Lopes E.C., Cheema S.S. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2001;2:127&#x2013;134. doi: 10.1080/146608201753275463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608201753275463</ArticleId><ArticleId IdType="pubmed">11771768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pehar M., Cassina P., Rene F., Castellanos R., Rouaux C., Gandelman M., Dimou L., Schwab M.E., Loeffler J.P., et al. Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc. Natl. Acad. Sci. USA. 2008;105:740&#x2013;745. doi: 10.1073/pnas.0703842105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0703842105</ArticleId><ArticleId IdType="pmc">PMC2206606</ArticleId><ArticleId IdType="pubmed">18182498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hempstead B.L. The many faces of p75NTR. Curr. Opin. Neurobiol. 2002;12:260&#x2013;267. doi: 10.1016/S0959-4388(02)00321-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-4388(02)00321-5</ArticleId><ArticleId IdType="pubmed">12049931</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.J., Cheah I.K., Macfarlane K.J., Lopes E.C., Petratos S., Langford S.J., Cheema S.S. Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J. Neurochem. 2003;87:752&#x2013;763. doi: 10.1046/j.1471-4159.2003.02053.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02053.x</ArticleId><ArticleId IdType="pubmed">14535957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard S.R., Chataway T., Schultz D.W., Rush R.A., Rogers M.-L. The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e87398. doi: 10.1371/journal.pone.0087398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087398</ArticleId><ArticleId IdType="pmc">PMC3903651</ArticleId><ArticleId IdType="pubmed">24475283</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;st B.M., Brouwer N., Mantingh I.J., Boddeke H.W.G.M., Copray J.C.V.M. Reduced p75NTR expression delays disease onset only in female mice of a transgenic model of familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2003;4:100&#x2013;105. doi: 10.1080/14660820310012745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310012745</ArticleId><ArticleId IdType="pubmed">14506941</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H.B., Yang J.-F., Dai Z., Lee C.W., Hung H.W., Feng Z.H., Ko C.-P. Differential effects of neurotrophins and schwann cell-derived signals on neuronal survival/growth and synaptogenesis. J. Neurosci. 2003;23:5050&#x2013;5060. doi: 10.1523/JNEUROSCI.23-12-05050.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-12-05050.2003</ArticleId><ArticleId IdType="pmc">PMC6741189</ArticleId><ArticleId IdType="pubmed">12832528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantilla C.B., Gransee H.M., Zhan W.-Z., Sieck G.C. Motoneuron BDNF/TrkB signaling enhances functional recovery after cervical spinal cord injury. Exp. Neurol. 2013;247:101&#x2013;109. doi: 10.1016/j.expneurol.2013.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.04.002</ArticleId><ArticleId IdType="pmc">PMC3742616</ArticleId><ArticleId IdType="pubmed">23583688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagahara A.H., Tuszynski M.H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 2011;10:209&#x2013;219. doi: 10.1038/nrd3366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3366</ArticleId><ArticleId IdType="pubmed">21358740</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols N.L., Satriotomo I., Allen L.L., Grebe A.M., Mitchell G.S. Mechanisms of enhanced phrenic long-term facilitation in SOD1 G93a rats. J. Neurosci. 2017;37:5834&#x2013;5845. doi: 10.1523/JNEUROSCI.3680-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3680-16.2017</ArticleId><ArticleId IdType="pmc">PMC5473203</ArticleId><ArticleId IdType="pubmed">28500219</ArticleId></ArticleIdList></Reference><Reference><Citation>Patapoutian A., Reichardt L.F. Trk receptors: Mediators of neurotrophin action. Curr. Opin. Neurobiol. 2001;11:272&#x2013;280. doi: 10.1016/S0959-4388(00)00208-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-4388(00)00208-7</ArticleId><ArticleId IdType="pubmed">11399424</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadal L., Garcia N., Hurtado E., Sim&#xf3; A., Tom&#xe0;s M., Lanuza M.A. Presynaptic Muscarinic Acetylcholine Receptors and TrkB Receptor Cooperate in the Elimination of Redundant Motor Nerve Terminals during Development. Front. Aging Neurosci. 2017;9:1&#x2013;7. doi: 10.3389/fnagi.2017.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00024</ArticleId><ArticleId IdType="pmc">PMC5296322</ArticleId><ArticleId IdType="pubmed">28228723</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia N., Priego M., Obis T., Santafe M.M., Tom&#xe0;s M., Besalduch N., Lanuza Ma., Tom&#xe0;s J. Adenosine A1 and A2A receptor-mediated modulation of acetylcholine release in the mice neuromuscular junction. Eur. J. Neurosci. 2013;38:2229&#x2013;2241. doi: 10.1111/ejn.12220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.12220</ArticleId><ArticleId IdType="pubmed">23607735</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom&#xe0;s J., Garcia N., Lanuza M.A., Santaf&#xe9; M.M., Tom&#xe0;s M., Nadal L., Hurtado E., Sim&#xf3; A., Cilleros V. Presynaptic Membrane Receptors Modulate ACh Release, Axonal Competition and Synapse Elimination during Neuromuscular Junction Development. Front. Mol. Neurosci. 2017;10:1&#x2013;12. doi: 10.3389/fnmol.2017.00132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00132</ArticleId><ArticleId IdType="pmc">PMC5432534</ArticleId><ArticleId IdType="pubmed">28559796</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.-X., Jia M., Yang L.-X., Jiang H., Lanuza M.A., Gonzalez C.M., Nelson P.G. The Role of the Theta Isoform of Protein Kinase C (PKC) in Activity-Dependent Synapse Elimination: Evidence from the PKC Theta Knock-Out Mouse In Vivo and In Vitro. J. Neurosci. 2004;24:3762&#x2013;3769. doi: 10.1523/JNEUROSCI.3930-03.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3930-03.2004</ArticleId><ArticleId IdType="pmc">PMC6729339</ArticleId><ArticleId IdType="pubmed">15084656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanuza M.A., Besalduch N., Gonz&#xe1;lez C., Santaf&#xe9; M.M., Garcia N., Tom&#xe0;s M., Nelson P.G., Tom&#xe0;s J. Decreased phosphorylation of &#x3b4; and &#x3b5; subunits of the acetylcholine receptor coincides with delayed postsynaptic maturation in PKC &#x3b8; deficient mouse. Exp. Neurol. 2010;225:183&#x2013;195. doi: 10.1016/j.expneurol.2010.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.06.014</ArticleId><ArticleId IdType="pubmed">20599977</ArticleId></ArticleIdList></Reference><Reference><Citation>Camerino G.M., Fonzino A., Conte E., De Bellis M., Mele A., Liantonio A., Tricarico D., Tarantino N., Dobrowolny G., Musar&#xf2; A., et al. Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options. Sci. Rep. 2019;9:3185. doi: 10.1038/s41598-019-39676-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39676-3</ArticleId><ArticleId IdType="pmc">PMC6395744</ArticleId><ArticleId IdType="pubmed">30816241</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Martini M., Scicchitano B.M., Romanello V., Boncompagni S., Nicoletti C., Pietrangelo L., De Panfilis S., Catizone A., Bouch&#xe8; M., et al. Muscle Expression of SOD1 G93A Triggers the Dismantlement of Neuromuscular Junction via PKC-Theta. Antioxid. Redox Signal. 2018;28:1105&#x2013;1119. doi: 10.1089/ars.2017.7054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7054</ArticleId><ArticleId IdType="pubmed">28931313</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M., Kato S., Oda M., Hirai S. Decrease of protein kinase C in the spinal motor neurons of amyotrophic lateral sclerosis. Acta. Neuropathol. 1998;96:52&#x2013;56. doi: 10.1007/s004010050859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050859</ArticleId><ArticleId IdType="pubmed">9678513</ArticleId></ArticleIdList></Reference><Reference><Citation>Plomp J.J., Vergouwe M.N., Van den Maagdenberg A.M., Ferrari M.D., Frants R.R., Molenaar P.C. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha1A Ca2+ channel mutation. Brain. 2000;123:463&#x2013;471. doi: 10.1093/brain/123.3.463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.3.463</ArticleId><ArticleId IdType="pubmed">10686170</ArticleId></ArticleIdList></Reference><Reference><Citation>Felipo V., Mi&#xf1;ana M.D., Grisol&#xed;a S. Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures. Brain Res. 1993;604:192&#x2013;196. doi: 10.1016/0006-8993(93)90368-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(93)90368-W</ArticleId><ArticleId IdType="pubmed">7681344</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger C., Lanius R.A., Pelech S.L., Shaw C. a Amyotrophic lateral sclerosis: The involvement of intracellular Ca2+ and protein kinase C. Trends Pharm. Sci. 1996;17:114&#x2013;120. doi: 10.1016/0165-6147(96)10004-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-6147(96)10004-3</ArticleId><ArticleId IdType="pubmed">8936348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondola P., Damiano S., Sasso A., Santillo M. The Cu, Zn Superoxide Dismutase: Not Only a Dismutase Enzyme. Front. Physiol. 2016;7:1&#x2013;8. doi: 10.3389/fphys.2016.00594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00594</ArticleId><ArticleId IdType="pmc">PMC5126113</ArticleId><ArticleId IdType="pubmed">27965593</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger C., Hu J.H., Pelech S. Aberrant protein kinases and phosphoproteins in amyotrophic lateral sclerosis. Trends Pharm. Sci. 2003;24:535&#x2013;541. doi: 10.1016/j.tips.2003.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2003.08.003</ArticleId><ArticleId IdType="pubmed">14559406</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A. Clinical Electrophysiology of the Upper and Lower Motor Neuron in Amyotrophic Lateral Sclerosis. Semin. Neurol. 2001;21:141&#x2013;154. doi: 10.1055/s-2001-15261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2001-15261</ArticleId><ArticleId IdType="pubmed">11442323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha M.C., Pousinha P.A., Correia A.M., Sebasti&#xe3;o A.M., Ribeiro J.A. Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset. PLoS ONE. 2013;8:1&#x2013;11. doi: 10.1371/journal.pone.0073846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood S.J., Slater C.R. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J. Physiol. 1997;500:165&#x2013;176. doi: 10.1113/jphysiol.1997.sp022007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1997.sp022007</ArticleId><ArticleId IdType="pmc">PMC1159367</ArticleId><ArticleId IdType="pubmed">9097941</ArticleId></ArticleIdList></Reference><Reference><Citation>Andonian M.H., Fahim M.A. Effects of endurance exercise on the morphology of mouse neuromuscular junctions during ageing. J. Neurocytol. 1987;16:589&#x2013;599. doi: 10.1007/BF01637652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01637652</ArticleId><ArticleId IdType="pubmed">3694234</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas J., Batlle J., Fenoll M.R., Santaf&#xe9; M., Lanuza M.A. Activity-dependent plastic changes in the motor nerve terminals of the adult rat. Biol. Cell. 1993;79:133&#x2013;137. doi: 10.1111/j.1768-322X.1993.tb00903.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1768-322X.1993.tb00903.x</ArticleId><ArticleId IdType="pubmed">8161966</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas J., Santaf&#xe9; M., Lanuza M.A., Fenoll-Brunet M.R. Physiological activity-dependent ultrastructural plasticity in normal adult rat neuromuscular junctions. Biol. Cell. 1997;89:19&#x2013;28. doi: 10.1016/S0248-4900(99)80078-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0248-4900(99)80078-1</ArticleId><ArticleId IdType="pubmed">9297780</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschenes M.R., Maresh C.M., Crivello J.F., Armstrong L.E., Kraemer W.J., Covault J. The effects of exercise training of different intensities on neuromuscular junction morphology. J. Neurocytol. 1993;22:603&#x2013;615. doi: 10.1007/BF01181487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01181487</ArticleId><ArticleId IdType="pubmed">8229087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorl&#xf6;chter M., Irintchev A., Brinkers M., Wernig A. Effects of enhanced activity on synaptic transmission in mouse extensor digitorum longus muscle. J. Physiol. 1991;436:283&#x2013;292. doi: 10.1113/jphysiol.1991.sp018550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1991.sp018550</ArticleId><ArticleId IdType="pmc">PMC1181505</ArticleId><ArticleId IdType="pubmed">1648130</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain K., Somani S.M. Response of cardiac antioxidant system to alcohol and exercise training in the rat. Alcohol. 1997;14:301&#x2013;307. doi: 10.1016/S0741-8329(96)00211-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-8329(96)00211-X</ArticleId><ArticleId IdType="pubmed">9160808</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki H., Oh-ishi S., Ookawara T., Kizaki T., Toshinai K., Ha S., Haga S., Ji L.L., Ohno H. Strenuous endurance training in humans reduces oxidative stress following exhausting exercise. Eur. J. Appl. Physiol. 2001;84:1&#x2013;6. doi: 10.1007/s004210000342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004210000342</ArticleId><ArticleId IdType="pubmed">11394236</ArticleId></ArticleIdList></Reference><Reference><Citation>Holloszy J.O., Oscai L.B., Don I.J., Mol&#xe9; P.A. Mitochondrial citric acid cycle and related enzymes: Adaptive response to exercise. Biochem. Biophys. Res. Commun. 1970;40:1368&#x2013;1373. doi: 10.1016/0006-291X(70)90017-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(70)90017-3</ArticleId><ArticleId IdType="pubmed">4327015</ArticleId></ArticleIdList></Reference><Reference><Citation>Acsadi G., Anguelov R.A., Yang H., Toth G., Thomas R., Jani A., Wang Y., Ianakova E., Mohammad S., Lewis R.A., et al. Increased Survival and Function of SOD1 Mice After Glial Cell-Derived Neurotrophic Factor Gene Therapy. Hum. Gene. 2002;13:1047&#x2013;1059. doi: 10.1089/104303402753812458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/104303402753812458</ArticleId><ArticleId IdType="pubmed">12067438</ArticleId></ArticleIdList></Reference><Reference><Citation>Manabe Y., Nagano I., Gazi M.S.A., Murakami T., Shiote M., Shoji M., Kitagawa H., Setoguchi Y., Abe K. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Apoptosis. 2002;7:329&#x2013;334. doi: 10.1023/A:1016123413038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016123413038</ArticleId><ArticleId IdType="pubmed">12101392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W., Funakoshi H., Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci. 2002;22:6537&#x2013;6548. doi: 10.1523/JNEUROSCI.22-15-06537.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-15-06537.2002</ArticleId><ArticleId IdType="pmc">PMC6758174</ArticleId><ArticleId IdType="pubmed">12151533</ArticleId></ArticleIdList></Reference><Reference><Citation>Drory V.E., Goltsman E., Reznik J.G., Mosek A., Korczyn A.D. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2001;191:133&#x2013;137. doi: 10.1016/S0022-510X(01)00610-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00610-4</ArticleId><ArticleId IdType="pubmed">11677004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto A.C., Alves M., Nogueira A., Evangelista T., Carvalho J., Coelho A., de Carvalho M., Sales-Lu&#xed;s M.L. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J. Neurol. Sci. 1999;169:69&#x2013;75. doi: 10.1016/S0022-510X(99)00218-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00218-X</ArticleId><ArticleId IdType="pubmed">10540010</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T., Tyreman N., Li S., Putman C.T., Hegedus J. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2010;37:412&#x2013;422. doi: 10.1016/j.nbd.2009.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.10.021</ArticleId><ArticleId IdType="pubmed">19879358</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Haas V.D., Florence J.M., Kloos A.D., Scheirbecker J., Lopate G., Hayes S.M., Pioro E.P., Mitsumoto H. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. 2007;68:2003&#x2013;2007. doi: 10.1212/01.wnl.0000264418.92308.a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000264418.92308.a4</ArticleId><ArticleId IdType="pubmed">17548549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C., Lizio A., Sansone V.A., Cellotto N.M., Maestri E., Bettinelli M., Gatti V., Melazzini M.G., Meola G., Corbo M. Strictly monitored exercise programs reduce motor deterioration in ALS: Preliminary results of a randomized controlled trial. J. Neurol. 2016;263:52&#x2013;60. doi: 10.1007/s00415-015-7924-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7924-z</ArticleId><ArticleId IdType="pubmed">26477027</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer R., Spittel S., Steinfurth L., Funke A., Kettemann D., M&#xfc;nch C., Meyer T., Maier A. Patient-Reported Outcome of Physical Therapy in Amyotrophic Lateral Sclerosis: Observational Online Study. JMIR Rehabil. Assist. Technol. 2018;5:e10099. doi: 10.2196/10099.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10099</ArticleId><ArticleId IdType="pmc">PMC6256108</ArticleId><ArticleId IdType="pubmed">30425026</ArticleId></ArticleIdList></Reference><Reference><Citation>Merico A., Cavinato M., Gregorio C., Lacatena A., Gioia E., Piccione F., Angelini C. Effects of combined endurance and resistance training in Amyotrophic Lateral Sclerosis: A pilot, randomized, controlled study. Eur. J. Transl. Myol. 2018;28:72&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5895987</ArticleId><ArticleId IdType="pubmed">29686818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar B.K., Frost L.M., Christian L., Umapathi P., Gage F.H. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann. Neurol. 2005;57:649&#x2013;655. doi: 10.1002/ana.20451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20451</ArticleId><ArticleId IdType="pubmed">15852403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos I.G., Hernandez D., Bradley W.G., Moraes C.T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 2003;53:804&#x2013;807. doi: 10.1002/ana.10597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10597</ArticleId><ArticleId IdType="pubmed">12783429</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink J.H., B&#xe4;r P.R., Joosten E.A.J., Otten M., Wokke J.H.J., Van Den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 2003;13:737&#x2013;743. doi: 10.1016/S0960-8966(03)00104-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(03)00104-4</ArticleId><ArticleId IdType="pubmed">14561497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney D.J., Rodriguez C., Devries M., Yasuda N., Tarnopolsky M.A. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29:656&#x2013;662. doi: 10.1002/mus.20004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20004</ArticleId><ArticleId IdType="pubmed">15116368</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras I., Yuruker S., Aytan N., Hossain L., Choi J.-K., Jenkins B.G., Kowall N.W., Dedeoglu A. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res. 2010;1313:192&#x2013;201. doi: 10.1016/j.brainres.2009.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.11.051</ArticleId><ArticleId IdType="pmc">PMC2892864</ArticleId><ArticleId IdType="pubmed">19968977</ArticleId></ArticleIdList></Reference><Reference><Citation>Just-Borr&#xe0;s L., Hurtado E., Cilleros-Ma&#xf1;&#xe9; V., Biondi O., Charbonnier F., Tom&#xe0;s M., Garcia N., Tom&#xe0;s J., Lanuza M.A. Running and swimming prevent the deregulation of the BDNF/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis. Cell. Mol. Life Sci. 2019 doi: 10.1007/s00018-019-03337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03337-5</ArticleId><ArticleId IdType="pubmed">31646358</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A., Pitzer C., Schneider A. Henriques Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: Where do we stand? Front. Neurosci. 2010;4:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902233</ArticleId><ArticleId IdType="pubmed">20592948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Matti U., Nehring R.B., Binz T., Rettig J., Neher E., S&#xf8;rensen J.B. Protein kinase C-dependent phosphorylation of synaptosome-associated protein of 25 kDa at Ser187 potentiates vesicle recruitment. J. Neurosci. 2002;22:9278&#x2013;9286. doi: 10.1523/JNEUROSCI.22-21-09278.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-21-09278.2002</ArticleId><ArticleId IdType="pmc">PMC6758053</ArticleId><ArticleId IdType="pubmed">12417653</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>de Majo M., Topp S.D., Smith B.N., Nishimura A.L., Chen H.-J., Gkazi A.S., Miller J., Wong C.H., Vance C., Baas F., et al. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol. Aging. 2018;71:1&#x2013;10. doi: 10.1016/j.neurobiolaging.2018.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.015</ArticleId><ArticleId IdType="pmc">PMC6983933</ArticleId><ArticleId IdType="pubmed">30033073</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M., Arko-Mensah J., Ponpuak M., Roberts E., Master S., Mandell M.A., Dupont N., Ornatowski W., Jiang S., Bradfute S.B., et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37:223&#x2013;234. doi: 10.1016/j.immuni.2012.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.04.015</ArticleId><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke A.L., Delbridge L.M., Balachandran S., Barber G.N., O&#x2019;Riordan M.X.D. TBK1 protects vacuolar integrity during intracellular bacterial infection. PLoS Pathog. 2007;3:e29. doi: 10.1371/journal.ppat.0030029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0030029</ArticleId><ArticleId IdType="pmc">PMC1808071</ArticleId><ArticleId IdType="pubmed">17335348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228&#x2013;233. doi: 10.1126/science.1205405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205405</ArticleId><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Korac J., Schaeffer V., Kovacevic I., Clement A.M., Jungblut B., Behl C., Terzic J., Dikic I. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 2013;126:580&#x2013;592. doi: 10.1242/jcs.114926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.114926</ArticleId><ArticleId IdType="pmc">PMC3654196</ArticleId><ArticleId IdType="pubmed">23178947</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#x2019;Diaye E.-N., Debnath J., Brown E.J. Ubiquilins accelerate autophagosome maturation and promote cell survival during nutrient starvation. Autophagy. 2009;5:573&#x2013;575. doi: 10.4161/auto.5.4.8312.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.4.8312</ArticleId><ArticleId IdType="pubmed">19398896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg C., Srinivasan D., Mah L., Kaushik S., Peterhoff C.M., Ugolino J., Fang S., Cuervo A.M., Nixon R.A., Monteiro M.J. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 2010;19:3219&#x2013;3232. doi: 10.1093/hmg/ddq231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq231</ArticleId><ArticleId IdType="pmc">PMC2908472</ArticleId><ArticleId IdType="pubmed">20529957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L.F. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. USA. 2014;111:4439&#x2013;4448. doi: 10.1073/pnas.1405752111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405752111</ArticleId><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J.-M., Ordureau A., Paulo J.A., Rinehart J., Harper J.W. The PINK1-PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 Recruitment and TBK1 Activation to Promote Mitophagy. Mol. Cell. 2015;60:7&#x2013;20. doi: 10.1016/j.molcel.2015.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.08.016</ArticleId><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton S., Hesson L., Peggie M., Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 2008;582:997&#x2013;1002. doi: 10.1016/j.febslet.2008.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.02.047</ArticleId><ArticleId IdType="pubmed">18307994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Ofengeim D., Najafov A., Das S., Saberi S., Li Y., Hitomi J., Zhu H., Chen H., Mayo L., et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;608. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x158;eho&#x159;ov&#xe1; M., Vargov&#xe1; I., Forostyak S., Vackov&#xe1; I., Turnovcov&#xe1; K., Kupcov&#xe1; Skaln&#xed;kov&#xe1; H., Vodi&#x10d;ka P., Kubinov&#xe1; &#x160;., Sykov&#xe1; E., Jendelov&#xe1; P. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1 G93A Rats. Stem Cells Transl. Med. 2019;8:535&#x2013;547. doi: 10.1002/sctm.18-0223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0223</ArticleId><ArticleId IdType="pmc">PMC6525562</ArticleId><ArticleId IdType="pubmed">30802001</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado C.B., Pluchon P., Harley P., Rigby M., Gonzalez Sabater V., Stevenson D.C., Hynes S., Lowe A., Burrone J., Viasnoff V., et al. In Vitro Modelling of Nerve-Muscle Connectivity in a Compartmentalised Tissue Culture Device. Adv. Biosyst. 2019;3 doi: 10.1002/adbi.201800307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.201800307</ArticleId><ArticleId IdType="pmc">PMC6699992</ArticleId><ArticleId IdType="pubmed">31428672</ArticleId></ArticleIdList></Reference><Reference><Citation>Burden S.J., Yumoto N., Zhang W. The Role of MuSK in Synapse Formation and Neuromuscular Disease. Cold Spring Harb. Perspect. Biol. 2013;5:a009167. doi: 10.1101/cshperspect.a009167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a009167</ArticleId><ArticleId IdType="pmc">PMC3632064</ArticleId><ArticleId IdType="pubmed">23637281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilmont V., Cadot B., Vezin E., Le Grand F., Gomes E.R. Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: Implication in ALS. Sci. Rep. 2016;6:27804. doi: 10.1038/srep27804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27804</ArticleId><ArticleId IdType="pmc">PMC4901269</ArticleId><ArticleId IdType="pubmed">27283349</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta-Ghosh A., Dominguez S.L., Xie L., Barck K.H., Jiang Z., Earr T., Imperio J., Phu L., Budayeva H.G., Kirkpatrick D.S., et al. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1 G93A mouse model of ALS. Neurobiol. Dis. 2019;124:340&#x2013;352. doi: 10.1016/j.nbd.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.002</ArticleId><ArticleId IdType="pubmed">30528255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor S., Zhang W., Delestr&#xe9;e N., Rem&#xe9;dio L., Mentis G.Z., Burden S.J. Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody. eLife. 2018;7:1&#x2013;20. doi: 10.7554/eLife.34375.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34375</ArticleId><ArticleId IdType="pmc">PMC5837562</ArticleId><ArticleId IdType="pubmed">29460776</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi S., Tezuka T., Arimura S., Tomono T., Okada T., Yamanashi Y. DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol. Med. 2017;9:880&#x2013;889. doi: 10.15252/emmm.201607298.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607298</ArticleId><ArticleId IdType="pmc">PMC5494517</ArticleId><ArticleId IdType="pubmed">28490573</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Garcia M.J., Burden S.J. Increasing MuSK Activity Delays Denervation and Improves Motor Function in ALS Mice. Cell Rep. 2012;2:497. doi: 10.1016/j.celrep.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.004</ArticleId><ArticleId IdType="pmc">PMC3462266</ArticleId><ArticleId IdType="pubmed">22939980</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorlewicz A., Wlodarczyk J., Wilczek E., Gawlak M., Cabaj A., Majczynski H., Nestorowicz K., Herbik M.A., Grieb P., Slawinska U., et al. CD44 is expressed in non-myelinating Schwann cells of the adult rat, and may play a role in neurodegeneration-induced glial plasticity at the neuromuscular junction. Neurobiol. Dis. 2009;34:245&#x2013;258. doi: 10.1016/j.nbd.2009.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.01.011</ArticleId><ArticleId IdType="pubmed">19385056</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H., Belzil V.V., Dion P.A., Higasa K., Doi K., et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am. J. Hum. Genet. 2013;93:900&#x2013;905. doi: 10.1016/j.ajhg.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O., Garc&#xed;a-Redondo A., Rojas-Garc&#xed;a R., Borrego-Hern&#xe1;ndez D., Ill&#xe1;n-Gala I., Mu&#xf1;oz-Blanco J.L., R&#xe1;bano A., Cervera-Carles L., Ju&#xe1;rez-Rufi&#xe1;n A., Spataro N., et al. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation. J. Neurol. Neurosurg. Psychiatry. 2018;89:162&#x2013;168. doi: 10.1136/jnnp-2017-316820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316820</ArticleId><ArticleId IdType="pubmed">28889094</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pichon C.E., Dominguez S.L., Solanoy H., Ngu H., Lewin-Koh N., Chen M., Eastham-Anderson J., Watts R., Scearce-Levie K. EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS. PLoS ONE. 2013;8:e62342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637182</ArticleId><ArticleId IdType="pubmed">23638043</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L., Modena M., Lo Gerfo A., Ricci G., Caldarazzo Ienco E., Ryskalin L., Fornai F., Siciliano G. Cross-talk between pathogenic mechanisms in neurodegeneration: The role of oxidative stress in Amyotrophic Lateral Sclerosis. Arch. Ital. Biol. 2017;155:131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">29405030</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Cleveland D.W. Revisiting oxidative damage in ALS: Microglia, Nox, and mutant SOD1. J. Clin. Investig. 2008;118:474&#x2013;478. doi: 10.1172/JCI34613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI34613</ArticleId><ArticleId IdType="pmc">PMC2213376</ArticleId><ArticleId IdType="pubmed">18219386</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez A.O., Morgan K.L., Szewczyk N.J., Gems D., Estevez M. The neurodegenerative effects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulin-like growth factor signaling in Caenorhabditis elegans. Neurotoxicology. 2014;41:28&#x2013;43. doi: 10.1016/j.neuro.2013.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2013.12.012</ArticleId><ArticleId IdType="pmc">PMC3979119</ArticleId><ArticleId IdType="pubmed">24406377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N.C., Tresse E., Kolaitis R.-M., Molliex A., Thomas R.E., Alami N.H., Wang B., Joshi A., Smith R.B., Ritson G.P., et al. VCP Is Essential for Mitochondrial Quality Control by PINK1/Parkin and this Function Is Impaired by VCP Mutations. Neuron. 2013;78:65&#x2013;80. doi: 10.1016/j.neuron.2013.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.029</ArticleId><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L.F. Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria. Autophagy. 2015;11:422&#x2013;434. doi: 10.1080/15548627.2015.1009792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1009792</ArticleId><ArticleId IdType="pmc">PMC4502688</ArticleId><ArticleId IdType="pubmed">25801386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouhan A.K., Zhang J., Zinsmaier K.E., Macleod G.T. Presynaptic Mitochondria in Functionally Different Motor Neurons Exhibit Similar Affinities for Ca2+ But Exert Little Influence as Ca2+ Buffers at Nerve Firing Rates In Situ. J. Neurosci. 2010;30:1869&#x2013;1881. doi: 10.1523/JNEUROSCI.4701-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4701-09.2010</ArticleId><ArticleId IdType="pmc">PMC2824909</ArticleId><ArticleId IdType="pubmed">20130196</ArticleId></ArticleIdList></Reference><Reference><Citation>Recabarren-Leiva D., Alarc&#xf3;n M. New insights into the gene expression associated to amyotrophic lateral sclerosis. Life Sci. 2018;193:110&#x2013;123. doi: 10.1016/j.lfs.2017.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.12.016</ArticleId><ArticleId IdType="pubmed">29241710</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;ger B., Vergani L., Sorar&#xf9; G., Hespel P., Derave W., Gobelet C., D&#x2019;Ascenzio C., Angelini C., Russell A.P. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583&#x2013;585. doi: 10.1096/fj.05-5249fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5249fje</ArticleId><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Igoa M., Calvo A.C., Penas C., Manzano R., Oliv&#xe1;n S., Mu&#xf1;oz M.J., Mancuso R., Zaragoza P., Aguilera J., Navarro X., et al. Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy. J. Mol. Med. 2010;88:297&#x2013;308. doi: 10.1007/s00109-009-0556-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-009-0556-y</ArticleId><ArticleId IdType="pubmed">19921501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Ning K., Ferraiuolo L., Heath P.R., Ismail A., Kuo S.-W., Valori C.F., Cox L., Sharrack B., Wharton S.B., et al. Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:506&#x2013;517. doi: 10.1093/brain/awq345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq345</ArticleId><ArticleId IdType="pmc">PMC3030763</ArticleId><ArticleId IdType="pubmed">21228060</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>